Biogen · 5 hours ago
Engineer III, Automation
Triangle, NC
Full-time
Onsite
Entry, Mid Level
$75K/yr - $98K/yr
2+ years expBiogen is a mid-sized biotechnology company committed to delivering life-changing medicines. They are seeking a motivated Automation Engineer to support the administration and continuous improvement of critical automation platforms for large-scale biologics production.
BiotechnologyHealth CareNeuroscienceTherapeutics
Responsibilities
Provide daily administration, monitoring, and troubleshooting for the site’s Batch Control System (Emerson DeltaV)
Support Single-Use Bioreactor operations by administering and maintaining TruBio control platforms
Maintain and configure the Manufacturing Data Historian and contextualization layers (OSIsoft PI, PI Vision, interfaces, and AF)
Support InfoBatch batch reporting integrations, configuration updates, and troubleshooting
Administer Building Management and Alarm Management platforms including FactoryTalk, TiPS, and TopView
Support Syncade system and database administration activities
Participate in automation upgrade projects, system hardening, patching, and lifecycle planning
Assist in designing, testing, documenting, and implementing system changes following GMP and validation requirements
Support system migrations, virtualization initiatives, server upgrades, and integration with IT infrastructure
Provide support as needed for manufacturing operations
Troubleshoot equipment, network, and software issues involving PLC, HMIs, historians, MES, and batch control systems
Work with cross-functional teams to diagnose and resolve automation-related deviations
Create and maintain system documentation, including user accounts, SOPs, configurations, and validation documentation
Ensure automation systems remain audit-ready and compliant with regulatory and corporate standards
Qualification
Required
Bachelor's degree in Engineering (Chemical, Electrical, Mechanical, or related field)
2–4 years of experience supporting automation or control systems in biotechnology, pharmaceutical, or regulated manufacturing environments
Experience with at least one of the following systems: DeltaV, TruBio, PI, InfoBatch, FactoryTalk, Syncade, or equivalent industrial automation platforms
Basic working knowledge of control system networks (VLANs, firewalls, virtual machines, domain/LDAP authentication)
Demonstrated ability to troubleshoot complex system interactions across multiple layers of automation architecture
Comfortable collaborating with teams outside of Automation – Process Engineering, Validation, Quality, etc
Preferred
Experience in GMP-regulated manufacturing environments
Familiarity with batch control logic, S88, 21 CFR Part 11, and data integrity principles
Knowledge of server management, virtualization (Nutanix, VMware), or Windows Server administration
Experience with scripting or automation tools (PowerShell, Python, SQL) is a plus
Benefits
Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation
Company
Biogen
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Founded in 1978Cambridge, Massachusetts, USA
5001-10000 employees
H1B Sponsorship
Biogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (100)
2024 (93)
2023 (101)
2022 (134)
2021 (104)
2020 (114)
Funding
Current Stage
Public CompanyTotal Funding
$1.5BKey Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO
Leadership Team
Robin C. Kramer
Executive Vice President, Chief Financial Officer
Priya Singhal
Executive Vice President, Head of Development
Recent News
thecanadianpressnews.ca
2025-12-24
2025-12-24
Company data provided by crunchbase